Product Information
AUSTEDO XR 42 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $499.2507 per EA under NDC 68546047556. Its NADAC has been published 41 times since Sep 17, 2025.
Strength
42 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546047556
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEUTETRABENAZINEApproval Type
New Drug (NDA)
FDA Application
NDA216354On Market Since
5/29/2024
Price Statistics
The NADAC for AUSTEDO XR 42 MG TABLET has been published 41 times since Sep 17, 2025, and over the history we have for it it has risen 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $499.2507 per EA |
|---|---|
| All-time high | $499.8409 (May 13, 2026) |
| All-time low | $471.7639 (Sep 17, 2025) |
| 52-week high | $499.8409 |
| 52-week low | $471.7639 |
| Median price | $499.2507 |
| Average price | $489.1490 |
| Largest weekly change | +5.5% (Jan 7, 2026) |
| Weeks tracked | 41 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AUSTEDO XR 42 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR 42 MG TABLET, manufactured by Teva Neuroscience, Inc., is $499.2507 per EA (NDC 68546047556), effective Jun 24, 2026.
How has the price of AUSTEDO XR 42 MG TABLET changed over time?
Over the history we have for it, the NADAC for AUSTEDO XR 42 MG TABLET has risen 5.8%. It has been tracked across 41 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for AUSTEDO XR 42 MG TABLET?
Since Sep 17, 2025, the NADAC for AUSTEDO XR 42 MG TABLET has ranged from a low of $471.7639 (Sep 17, 2025) to a high of $499.8409 (May 13, 2026), with a median of $499.2507 per EA.
Are there cheaper alternatives to AUSTEDO XR 42 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AUSTEDO XR 42 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO XR 42 MG TABLET?
AUSTEDO XR 42 MG TABLET (NDC 68546047556) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification